Immunotherapy Toxicity: More Questions than Answers
Kerry Reynolds, M.D., Clinical Director, Inpatient Oncology, Director, Severe Immunotherapy Complications Service, Massachusetts General Hospital Cancer Center, Assistant Professor of Medicine, Harvard Medical School
